FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 118_S_5222.
Which chamber initiated this legislation?
This legislation was initiated in the Senate.
When did the legislative process begin?
The process officially started on 2024-09-25.
What are the main provisions?
Key points include:
- Establishment of the MedShield program to operationalize a national medical shield against biological threats.
- Utilization of AI for real-time global pathogen surveillance and accelerating vaccine development.
- Streamlining and enhancing the rapid manufacturing of vaccines and therapeutics.
- Authorization of a total of $2 billion for fiscal years 2025–2029 (ranging from $300 million in 2025 to $500 million in 2029).
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Sen. Rounds, Mike [R-SD].
What is the latest detailed status?
The latest detailed status is: Introduced in Senate
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.
What is the impact of this bill?
We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.